POST Online Media Lite Edition



 

Agios Pharmaceuticals names chief commercial officer

Staff writer |
Cambridge, Mass., USA - February 9, 2016, Cambridge, Mass., USA - Agios Pharmaceuticals announced the appointment of Steve Hoerter to the newly created position of chief commercial officer from February 16, 2016.




Mr. Hoerter has more than 20 years of global pharmaceutical and biotechnology experience, most recently having served as executive vice president and chief commercial officer at Clovis Oncology as well as previous senior commercial roles at Genentech and Roche.

Before joining Clovis in 2011, he was general manager and management center head at Roche for the Sub-Saharan Africa and Indian Ocean Region.

From 2005 to 2010, Mr. Hoerter held a variety of positions at Genentech, Inc., including serving on the senior leadership team for Genentech’s BioOncology business as senior director, Pipeline Development and Commercial Operations.

Prior to that, Mr. Hoerter held commercial roles at Chiron Corporation and Eli Lilly and Company in the U.S., Europe and Africa.

LATEST 5 MOVES FROM Massachusetts 


What to read next

Agios Pharma names Ian Clark to board of directors
Blueprint Medicines appoints Marion Dorsch as CSO
Editas Medicine appoints Andrew Hirsch to board